Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.308 DKK | -2.10% | -2.53% | -37.42% |
Feb. 22 | Transcript : BioPorto A/S - Special Call | |
Feb. 22 | BioPorto A/S Provides Revenue Guidance for the Full Year 2024 | CI |
Business Summary
Number of employees: 33
Sales per Business
DKK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Neutrophil Gelatinase-associated Lipocalin
51.3
%
| 12 | 49.9 % | 15 | 51.3 % | +22.87% |
Antibodies
41.5
%
| 9 | 37.5 % | 12 | 41.5 % | +32.29% |
Enzyme-linked Immunosorbent Assay Kits
6.3
%
| 2 | 10.3 % | 2 | 6.3 % | -26.41% |
Royalty
0.8
%
| 0 | 0.3 % | 0 | 0.8 % | +285.71% |
Sales per region
DKK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
51.6
%
| 13 | 55.5 % | 15 | 51.6 % | +11.17% |
Europe
34.8
%
| 8 | 31.8 % | 10 | 34.8 % | +30.90% |
Asia
13.5
%
| 3 | 12.6 % | 4 | 13.5 % | +27.86% |
Other Countries
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | -76.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Chief Operating Officer | 63 | 15-10-03 | |
Sales & Marketing | - | 19-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 | |
Michael Singer
BRD | Director/Board Member | 51 | 19-08-14 |
Chief Operating Officer | 63 | 15-10-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 379,670,461 | 338,546,015 ( 89.17 %) | 13,000 ( 0.003424 %) | 89.17 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOPORTO A/S 0.00% | 13,000 | 0.00% | 2,982 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.42% | 72.05M | |
-4.69% | 8.1B | |
-3.88% | 5.13B | |
+2.96% | 4.72B | |
-34.08% | 4.4B | |
-2.48% | 4.14B | |
+15.50% | 2.82B | |
+3.24% | 2.55B | |
+11.81% | 1.92B | |
-1.77% | 1.65B |
- Stock
- Equities
- Stock BioPorto A/S - Nasdaq Copenhagen
- Company BioPorto A/S